Fumaric Acid

Fumaric Acid

SCHEMBL7002808

CC(C)c1cc2ncnn2nc1SCCCN1CCC(OC(c2ccccc2)c2ccccc2)CC1.O=C(O)C=CC(=O)O

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 3/20 0.41
HTR1A known ✓ P08908 3/20 0.41
ADRA1A known ✓ P35348 3/20 0.41
DRD2 known ✓ P14416 2/20 0.41
ADRA1D known ✓ P25100 2/20 0.41
ADRA1B known ✓ P35368 2/20 0.41
ADRA2A known ✓ P08913 2/20 0.41
DRD1 known ✓ P21728 2/20 0.41
SLC6A2 known ✓ P23975 2/20 0.41
SLC6A3 known ✓ Q01959 2/20 0.41
KCNH2 known ✓ Q12809 2/20 0.41
MLNR known ✓ O43193 1/20 0.41
EGFR known ✓ P00533 1/20 0.41
ERBB2 known ✓ P04626 1/20 0.41
ADRB1 known ✓ P08588 1/20 0.41
ADRA2B known ✓ P18089 1/20 0.41
ADRA2C known ✓ P18825 1/20 0.41
CHRM3 known ✓ P20309 1/20 0.41
HTR2A known ✓ P28223 1/20 0.41
HTR2C known ✓ P28335 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL7002804 1.00 BCHE (0.46) BCHECHRM2HTR1ACHRM1ADRA1A
SCHEMBL6622174 0.94 BCHE (0.45) BCHECHRM2HTR1ACHRM1ADRA1A
Fumaric Acid SCHEMBL6619772 0.89 BCHE (0.47) BCHECHRM2HTR1ACHRM1ADRA1A
Fumaric Acid SCHEMBL6619768 0.89 BCHE (0.47) BCHECHRM2HTR1ACHRM1ADRA1A
Fumaric Acid SCHEMBL7227367 0.87 BCHE (0.50) BCHECHRM2HTR1ACHRM1ADRA1A
Fumaric Acid SCHEMBL7009266 0.87 BCHE (0.50) BCHECHRM2HTR1ACHRM1ADRA1A
Fumaric Acid SCHEMBL6615862 0.85 BCHE (0.44) BCHECHRM2HTR1ACHRM1ADRA1A
Fumaric Acid SCHEMBL6615858 0.85 BCHE (0.44) BCHECHRM2HTR1ACHRM1ADRA1A
Fumaric Acid SCHEMBL7001483 0.84 BCHE (0.48) BCHECHRM2HTR1ACHRM1ADRA1A
Fumaric Acid SCHEMBL7001479 0.84 BCHE (0.48) BCHECHRM2HTR1ACHRM1ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1123936-B1 FUSED PYRIDAZINE DERIVATIVES, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-12-10 EP disclosed
US-6627630-B1 Preventing or treating allergic skin diseases such as contact dermatitis, pruritus, dried dermatitis, acute urticaria prurigo and antiallergins TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-30 US disclosed
EP-1243271-A1 NASAL DROPS CONTAINING FUSED PYRIDAZINE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2002-09-25 EP disclosed
EP-1123936-A1 FUSED PYRIDAZINE DERIVATIVES, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-08-16 EP disclosed